Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Clasificación en acciones #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Precio por acción
$0.02765
Última sincronización: 2024-12-23
Capitalización bursátil
$69.04K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Histogen Inc. (HSTO)

Categoría

Historial de desdoblamientos de acciones de Histogen Inc. (HSTO)
La acción Histogen Inc. (símbolo: HSTO) tuvo un total de 2 desdoblamientos.
El desdoblamiento más reciente ocurrió el Jun 03, 2022.
Una acción HSTO comprada antes de May 27, 2020 equivaldría hoy a 0.005 acciones HSTO.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
2022-06-03 1:20 x0.05 x0.005
2020-05-27 1:10 x0.1 x0.1
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE